Drug Profile
Trivalent cholera vaccine - Beijing Minhai Biotechnology
Alternative Names: 3-valent cholera oral vaccine - Beijing Minhai BiotechnologyLatest Information Update: 28 Jan 2018
Price :
$50
*
At a glance
- Originator Beijing Minhai Biotechnology
- Class Cholera vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cholera
Most Recent Events
- 28 Jan 2018 No recent reports of development identified for phase-I development in Cholera(Prevention) in China (PO)
- 02 Sep 2015 Beijing Minhai Biotechnology plans to launch trivalent cholera vaccine in 2017